Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Introduction to Language of Pathophysiology l01:25

Introduction to Language of Pathophysiology l

Pathophysiology investigates how biological mechanisms—typically starting at the cellular level—disrupt normal bodily functions. It bridges anatomy and physiology to explain the progression of disease. With this foundation, it is important to understand the following key terms used to describe disease processes: Diagnosis:The process of identifying a disease using clinical evaluation, including signs (objective evidence like rashes), symptoms (subjective experiences like pain), laboratory test...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Skin microbiome variation in people living with HIV: associations with antiretroviral therapy and host factors.

Frontiers in cellular and infection microbiology·2026
Same author

Comparison of serum vitamin D level and vitamin D receptor gene FokI polymorphism in leprosy patients with and without trophic ulcers: A case-control study.

PLoS neglected tropical diseases·2026
Same author

Atopic Dermatitis in Urban Indonesian Children: A Case-Control Study of the Prevalence of Filaggrin Loss-of-Function Variants and Sociodemographic Factors at a Tertiary Referral Hospital.

Dermatology (Basel, Switzerland)·2026
Same author

Profiling skin microbiota in an underrepresented population: Indonesian children with atopic dermatitis and controls.

Frontiers in medicine·2026
Same author

Transition of oral microbiome profile in HIV-infected Indonesian patients: the role of antiretroviral therapy.

Journal of oral microbiology·2026
Same author

Dermoscopic features of coral-contact dermatitis in a traveller returning from the Caribbean.

Journal of travel medicine·2025

Related Experiment Video

Updated: May 21, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Itch pathophysiology may differ among ethnic groups.

Enes Hajdarbegovic1, Hok Bing Thio

  • 1Department of Dermatology and Venereology, Erasmus Medical Centre, Rotterdam, the Netherlands. e.hajdarbegovic@erasmusmc.nl

International Journal of Dermatology
|June 22, 2012
PubMed
Summary

Itch is more common in people with darker skin. Differences in skin barrier function, mast cells, and itch receptors may explain why.

Area of Science:

  • Dermatology
  • Physiology
  • Immunology

Background:

  • Itch (pruritus) prevalence varies significantly across different populations.
  • Understanding the physiological underpinnings of itch disparities is crucial for targeted treatments.

Purpose of the Study:

  • To review the physiological systems involved in itch sensation.
  • To explore potential racial differences in itch physiology.
  • To identify factors contributing to higher itch prevalence in darker skin types.

Main Methods:

  • Literature review of studies on itch physiology.
  • Analysis of research on skin barrier function across races.
  • Examination of mast cell activity and receptor polymorphisms related to itch.

Related Experiment Videos

Last Updated: May 21, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Main Results:

  • Data suggests variations in skin barrier function between racial groups.
  • Differences in mast cell degranulation and histamine release may occur.
  • Polymorphisms in itch receptors (e.g., TRPV channels) might contribute to differential itch perception.

Conclusions:

  • The higher prevalence of itch in darker skin types may be attributed to distinct physiological mechanisms.
  • Factors include differences in epidermal barrier, immune cell responses, and sensory nerve signaling.
  • Further research is warranted to elucidate these racial variations in itch pathways.